Symetis has been battling Medtronic and Edwards Lifesciences for years in the European transcatheter aortic valve implantation market, and the company's aiming to squeeze out Boston Scientific, St. Jude Medical and other major players in the U.S.
Switzerland-based medical implant maker Symetis is looking to make some major moves in the global transcatheter aortic valve implantation market, and the company's not afraid to take on some of the medtech industry's biggest players.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nWW2Sx
Cap comentari:
Publica un comentari a l'entrada